Unbiased Analysis of Today's Healthcare Issues

Archive for the 'Current Events' Category

Friday Links

Wine and breast cancer. The promise of molecular imaging. The world’s most expensive drug? Who will be the binding constraint for drug access? 7 stages of robot replacement.

Read the rest of this entry »

Aligning Incentives

An interesting story at AJMC on a new type of wellness program that better aligns outcomes with reimbursement: “Most wellness programs are like most gym memberships,” Adam Fawer, Noom’s chief operating officer, said in an interview. Employers have spent lots of money on programs that fail to help or even reach most of the staff, […]

Read the rest of this entry »

Last Links Post of 2016

A “shadowy crony group”? The real 2016 celebrity deaths. “The GOP isn’t going to repeal ACA.” Economists versus the Economy. Art of the Deal coming to Rx?

Read the rest of this entry »

A Christmas present?

Good news reported from the NY Times: In a scientific triumph that will change the way the world fights a terrifying killer, an experimental Ebola vaccine tested on humans in the waning days of the West African epidemic has been shown to provide 100 percent protection against the lethal disease. The vaccine has not yet […]

Read the rest of this entry »

Staying healthy during the holidays

Christmas, Hanukah and Kwanza bring a sense of joy to many.  At the same time, the holiday times are often a time of stress as well.  There is financial pressure to buy presents for your children, pressure to make Christmas perfect, family members not getting along, etc. These and other challenges around the holidays problems […]

Read the rest of this entry »

Mid-week links

Unified theory of scarcity. Will price transparency cut costs? Potential. Surprise bills. Should academics partner with industry? Giannis!

Read the rest of this entry »

Friday Links

Does risk aversion change after a health shock. DCE vs. BWS. Does insurance cause high pharmaceutical prices? The latest developments in P4P. Drug prices rise, but ROI falls?

Read the rest of this entry »

Friday Links

CON laws don’t reduce mortality Why don’t people like pharma companies? Just give ‘em cash. Is value-based purchasing being undermined? Cancer drugs don’t live up to the hype?

Read the rest of this entry »

Friday Links

CRISPR=Sputnik 2.0 RIP Leibniz. Budget caps in Germany. Getting value frameworks right. Repeal and delay = the next ‘doc fix’?

Read the rest of this entry »

Friday Links

All or nothing FDA approval. Value of G-CSF. GMOs. “The curious have won.” Clinical trial disclosure. Barriers to value-based agreements. What is NexusACO?

Read the rest of this entry »